Coexpression cluster:C879
From FANTOM5_SSTAR
Full id: C879_Osteoblast_Adipocyte_Olfactory_leiomyoma_Smooth_tenocyte_Fibroblast
Phase1 CAGE Peaks
Hg19::chr11:119289293..119289305,- | p12@THY1 |
Hg19::chr11:119289671..119289701,- | p10@THY1 |
Hg19::chr11:119289738..119289754,- | p9@THY1 |
Hg19::chr11:119290792..119290808,- | p4@BC009328 |
Hg19::chr11:119290830..119290845,- | p6@BC009328 |
Hg19::chr11:119290894..119290943,- | p1@BC009328 |
Hg19::chr11:119291028..119291044,- | p3@BC009328 |
Hg19::chr11:119291053..119291082,- | p2@BC009328 |
Hg19::chr11:119291603..119291653,- | p4@THY1 |
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
No results for this coexpression
Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol | 0.00232123933996064 |
GO:0046549 | retinal cone cell development | 0.00232123933996064 |
GO:0042670 | retinal cone cell differentiation | 0.00232123933996064 |
GO:0060042 | retina morphogenesis in camera-type eye | 0.00232123933996064 |
GO:0050860 | negative regulation of T cell receptor signaling pathway | 0.00232123933996064 |
GO:0051279 | regulation of release of sequestered calcium ion into cytosol | 0.00232123933996064 |
GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway | 0.00232123933996064 |
GO:0060041 | retina development in camera-type eye | 0.00254881182427051 |
GO:0042462 | eye photoreceptor cell development | 0.00254881182427051 |
GO:0043547 | positive regulation of GTPase activity | 0.00254881182427051 |
GO:0050771 | negative regulation of axonogenesis | 0.00254881182427051 |
GO:0050856 | regulation of T cell receptor signaling pathway | 0.00254881182427051 |
GO:0001754 | eye photoreceptor cell differentiation | 0.00254881182427051 |
GO:0051283 | negative regulation of sequestering of calcium ion | 0.00254881182427051 |
GO:0042461 | photoreceptor cell development | 0.00254881182427051 |
GO:0051282 | regulation of sequestering of calcium ion | 0.00254881182427051 |
GO:0051209 | release of sequestered calcium ion into cytosol | 0.00254881182427051 |
GO:0051208 | sequestering of calcium ion | 0.00270811256328741 |
GO:0046530 | photoreceptor cell differentiation | 0.00270811256328741 |
GO:0050854 | regulation of antigen receptor-mediated signaling pathway | 0.00270811256328741 |
GO:0050768 | negative regulation of neurogenesis | 0.00293378861022803 |
GO:0048593 | camera-type eye morphogenesis | 0.00293378861022803 |
GO:0048041 | focal adhesion formation | 0.00293378861022803 |
GO:0051238 | sequestering of metal ion | 0.00293378861022803 |
GO:0050852 | T cell receptor signaling pathway | 0.00367529562160434 |
GO:0030426 | growth cone | 0.00367529562160434 |
GO:0030336 | negative regulation of cell migration | 0.00367529562160434 |
GO:0030427 | site of polarized growth | 0.00367529562160434 |
GO:0051271 | negative regulation of cell motility | 0.00419320654960631 |
GO:0005100 | Rho GTPase activator activity | 0.00419320654960631 |
GO:0040013 | negative regulation of locomotion | 0.00419320654960631 |
GO:0050770 | regulation of axonogenesis | 0.00426732888760441 |
GO:0048592 | eye morphogenesis | 0.00426732888760441 |
GO:0050851 | antigen receptor-mediated signaling pathway | 0.00430111995345648 |
GO:0002429 | immune response-activating cell surface receptor signaling pathway | 0.00464247867992128 |
GO:0002768 | immune response-regulating cell surface receptor signaling pathway | 0.00466397163677276 |
GO:0002757 | immune response-activating signal transduction | 0.00468430281217282 |
GO:0002764 | immune response-regulating signal transduction | 0.00470356392570971 |
GO:0043010 | camera-type eye development | 0.00472183728983446 |
GO:0050767 | regulation of neurogenesis | 0.00514541387024608 |
GO:0050870 | positive regulation of T cell activation | 0.00516430767882716 |
GO:0051235 | maintenance of localization | 0.00516430767882716 |
GO:0005178 | integrin binding | 0.00516430767882716 |
GO:0045121 | lipid raft | 0.00565694624331148 |
GO:0001654 | eye development | 0.00565694624331148 |
GO:0009897 | external side of plasma membrane | 0.00587718045649609 |
GO:0051251 | positive regulation of lymphocyte activation | 0.00587718045649609 |
GO:0006469 | negative regulation of protein kinase activity | 0.00624949053066326 |
GO:0033673 | negative regulation of kinase activity | 0.00624949053066326 |
GO:0051348 | negative regulation of transferase activity | 0.00624949053066326 |
GO:0050863 | regulation of T cell activation | 0.00624949053066326 |
GO:0030334 | regulation of cell migration | 0.00624949053066326 |
GO:0051270 | regulation of cell motility | 0.00681697300413728 |
GO:0051480 | cytosolic calcium ion homeostasis | 0.00681697300413728 |
GO:0007204 | elevation of cytosolic calcium ion concentration | 0.00681697300413728 |
GO:0002253 | activation of immune response | 0.00681697300413728 |
GO:0040012 | regulation of locomotion | 0.00681697300413728 |
GO:0040011 | locomotion | 0.00681697300413728 |
GO:0051345 | positive regulation of hydrolase activity | 0.00683687434010265 |
GO:0051249 | regulation of lymphocyte activation | 0.00683687434010265 |
GO:0051093 | negative regulation of developmental process | 0.00683687434010265 |
GO:0050865 | regulation of cell activation | 0.00698867758267719 |
GO:0050778 | positive regulation of immune response | 0.00713956948503045 |
GO:0007423 | sensory organ development | 0.00713956948503045 |
GO:0002684 | positive regulation of immune system process | 0.00713956948503045 |
GO:0043086 | negative regulation of catalytic activity | 0.00713956948503045 |
GO:0050776 | regulation of immune response | 0.00770477095470503 |
GO:0042110 | T cell activation | 0.00770477095470503 |
GO:0007160 | cell-matrix adhesion | 0.00770477095470503 |
GO:0002682 | regulation of immune system process | 0.00770477095470503 |
GO:0032403 | protein complex binding | 0.00770477095470503 |
GO:0031589 | cell-substrate adhesion | 0.00774821094496121 |
GO:0051240 | positive regulation of multicellular organismal process | 0.00779046079849803 |
GO:0007409 | axonogenesis | 0.00826686993003526 |
GO:0006874 | cellular calcium ion homeostasis | 0.00826686993003526 |
GO:0055074 | calcium ion homeostasis | 0.00826686993003526 |
GO:0048667 | neuron morphogenesis during differentiation | 0.00832249226766375 |
GO:0048812 | neurite morphogenesis | 0.00832249226766375 |
GO:0006875 | cellular metal ion homeostasis | 0.00832249226766375 |
GO:0055065 | metal ion homeostasis | 0.00832249226766375 |
GO:0000904 | cellular morphogenesis during differentiation | 0.00832249226766375 |
GO:0048503 | GPI anchor binding | 0.00832249226766375 |
GO:0001525 | angiogenesis | 0.00841798844973677 |
GO:0031175 | neurite development | 0.0087046475248524 |
GO:0048514 | blood vessel morphogenesis | 0.00932094556666365 |
GO:0009986 | cell surface | 0.00932094556666365 |
GO:0048646 | anatomical structure formation | 0.00943275162493369 |
GO:0048666 | neuron development | 0.00943275162493369 |
GO:0046649 | lymphocyte activation | 0.00943275162493369 |
GO:0001568 | blood vessel development | 0.00977275403273284 |
GO:0005099 | Ras GTPase activator activity | 0.00977275403273284 |
GO:0001944 | vasculature development | 0.00977275403273284 |
GO:0045321 | leukocyte activation | 0.0103714949232284 |
GO:0030005 | cellular di-, tri-valent inorganic cation homeostasis | 0.0103714949232284 |
GO:0055066 | di-, tri-valent inorganic cation homeostasis | 0.0104333599806652 |
GO:0030003 | cellular cation homeostasis | 0.0110490992582126 |
GO:0055080 | cation homeostasis | 0.0110490992582126 |
GO:0032990 | cell part morphogenesis | 0.0110490992582126 |
GO:0048858 | cell projection morphogenesis | 0.0110490992582126 |
GO:0030030 | cell projection organization and biogenesis | 0.0110490992582126 |
GO:0001775 | cell activation | 0.0110953738029834 |
GO:0030182 | neuron differentiation | 0.0110953738029834 |
GO:0043087 | regulation of GTPase activity | 0.0110953738029834 |
GO:0016477 | cell migration | 0.0118856051388725 |
GO:0050793 | regulation of developmental process | 0.0118856051388725 |
GO:0045859 | regulation of protein kinase activity | 0.0118856051388725 |
GO:0055082 | cellular chemical homeostasis | 0.0118856051388725 |
GO:0006873 | cellular ion homeostasis | 0.0118856051388725 |
GO:0048699 | generation of neurons | 0.0119156952784646 |
GO:0043549 | regulation of kinase activity | 0.0119156952784646 |
GO:0051338 | regulation of transferase activity | 0.012052320777153 |
GO:0035091 | phosphoinositide binding | 0.0121381473818775 |
GO:0043085 | positive regulation of catalytic activity | 0.0122703861274615 |
GO:0022008 | neurogenesis | 0.0124478156417772 |
GO:0050801 | ion homeostasis | 0.0125750618156129 |
GO:0051239 | regulation of multicellular organismal process | 0.0129335720694933 |
GO:0048878 | chemical homeostasis | 0.013980341779706 |
GO:0051336 | regulation of hydrolase activity | 0.014091365371682 |
GO:0005543 | phospholipid binding | 0.0152018419518991 |
GO:0016337 | cell-cell adhesion | 0.0155772425127937 |
GO:0005096 | GTPase activator activity | 0.0155772425127937 |
GO:0009887 | organ morphogenesis | 0.0160710942280335 |
GO:0019725 | cellular homeostasis | 0.0165128814834598 |
GO:0006928 | cell motility | 0.0165953137878253 |
GO:0051674 | localization of cell | 0.0165953137878253 |
GO:0008047 | enzyme activator activity | 0.0195585907348535 |
GO:0005083 | small GTPase regulator activity | 0.0199983696981224 |
GO:0000902 | cell morphogenesis | 0.0199983696981224 |
GO:0032989 | cellular structure morphogenesis | 0.0199983696981224 |
GO:0042592 | homeostatic process | 0.0199983696981224 |
GO:0005829 | cytosol | 0.0234840906251489 |
GO:0008289 | lipid binding | 0.0237575329415669 |
GO:0050790 | regulation of catalytic activity | 0.0246377158013366 |
GO:0065009 | regulation of a molecular function | 0.027121545223371 |
GO:0007010 | cytoskeleton organization and biogenesis | 0.0275224476802247 |
GO:0030695 | GTPase regulator activity | 0.0278776293279587 |
GO:0007399 | nervous system development | 0.0283066948220991 |
GO:0005783 | endoplasmic reticulum | 0.0355586953962086 |
GO:0065008 | regulation of biological quality | 0.0368764263937009 |
GO:0022610 | biological adhesion | 0.0368764263937009 |
GO:0007155 | cell adhesion | 0.0368764263937009 |
GO:0005102 | receptor binding | 0.0395537003961838 |
GO:0009653 | anatomical structure morphogenesis | 0.0396558580945723 |
GO:0048518 | positive regulation of biological process | 0.0399446603084893 |
GO:0048523 | negative regulation of cellular process | 0.042328170338506 |
GO:0048513 | organ development | 0.042328170338506 |
GO:0048519 | negative regulation of biological process | 0.0435127815911991 |
GO:0006955 | immune response | 0.0435127815911991 |
GO:0048468 | cell development | 0.0451473262228586 |
GO:0005887 | integral to plasma membrane | 0.0480238627889635 |
GO:0031226 | intrinsic to plasma membrane | 0.04827972861172 |
GO:0002376 | immune system process | 0.049387421219952 |
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>
Ontology term | p-value | n |
---|---|---|
fibroblast | 2.33e-21 | 76 |
preadipocyte | 5.78e-09 | 12 |
skin fibroblast | 6.80e-09 | 23 |
mesenchymal stem cell of adipose | 7.40e-07 | 8 |
Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
MA0003.1 | 0.169975 |
MA0004.1 | 3.82528 |
MA0006.1 | 0.265592 |
MA0007.1 | 0.397529 |
MA0009.1 | 0.870971 |
MA0014.1 | 0.0324647 |
MA0017.1 | 0.301634 |
MA0019.1 | 0.558663 |
MA0024.1 | 0.766783 |
MA0025.1 | 1.00397 |
MA0027.1 | 2.48103 |
MA0028.1 | 0.280275 |
MA0029.1 | 0.785955 |
MA0030.1 | 0.774581 |
MA0031.1 | 0.710608 |
MA0038.1 | 0.514558 |
MA0040.1 | 0.791764 |
MA0041.1 | 0.433167 |
MA0042.1 | 0.402577 |
MA0043.1 | 0.871285 |
MA0046.1 | 0.860127 |
MA0048.1 | 0.0764047 |
MA0050.1 | 0.403421 |
MA0051.1 | 0.510444 |
MA0052.1 | 0.795605 |
MA0055.1 | 0.0199484 |
MA0056.1 | 0 |
MA0057.1 | 0.539841 |
MA0058.1 | 3.27605 |
MA0059.1 | 5.28745 |
MA0060.1 | 0.162248 |
MA0061.1 | 0.432181 |
MA0063.1 | 0 |
MA0066.1 | 0.514973 |
MA0067.1 | 1.18766 |
MA0068.1 | 0.354973 |
MA0069.1 | 0.856287 |
MA0070.1 | 0.845142 |
MA0071.1 | 1.20007 |
MA0072.1 | 0.840664 |
MA0073.1 | 0.0776172 |
MA0074.1 | 0.509711 |
MA0076.1 | 0.339975 |
MA0077.1 | 0.832987 |
MA0078.1 | 0.607575 |
MA0081.1 | 0.324031 |
MA0083.1 | 0.878452 |
MA0084.1 | 1.37471 |
MA0087.1 | 0.838229 |
MA0088.1 | 1.01254 |
MA0089.1 | 0 |
MA0090.1 | 0.353576 |
MA0091.1 | 0.417885 |
MA0092.1 | 0.381858 |
MA0093.1 | 2.08959 |
MA0095.1 | 0 |
MA0098.1 | 0 |
MA0100.1 | 0.528088 |
MA0101.1 | 0.271368 |
MA0103.1 | 0.714036 |
MA0105.1 | 0.229733 |
MA0106.1 | 1.366 |
MA0107.1 | 0.205358 |
MA0108.2 | 0.707575 |
MA0109.1 | 0 |
MA0111.1 | 0.959847 |
MA0113.1 | 0.57094 |
MA0114.1 | 0.582067 |
MA0115.1 | 1.11137 |
MA0116.1 | 0.599942 |
MA0117.1 | 0.908433 |
MA0119.1 | 0.308914 |
MA0122.1 | 0.934245 |
MA0124.1 | 1.06995 |
MA0125.1 | 0.986127 |
MA0130.1 | 0 |
MA0131.1 | 0.625452 |
MA0132.1 | 0 |
MA0133.1 | 0 |
MA0135.1 | 0.90122 |
MA0136.1 | 0.521435 |
MA0139.1 | 0.129876 |
MA0140.1 | 0.474342 |
MA0141.1 | 0.861836 |
MA0142.1 | 0.679161 |
MA0143.1 | 0.571113 |
MA0144.1 | 0.1885 |
MA0145.1 | 0.177438 |
MA0146.1 | 0.0794051 |
MA0147.1 | 1.7891 |
MA0148.1 | 1.11902 |
MA0149.1 | 1.17441 |
MA0062.2 | 0.135498 |
MA0035.2 | 0.473658 |
MA0039.2 | 0.109483 |
MA0138.2 | 0.608783 |
MA0002.2 | 0.152495 |
MA0137.2 | 0.28622 |
MA0104.2 | 1.50683 |
MA0047.2 | 0.542971 |
MA0112.2 | 3.76262 |
MA0065.2 | 0.0483532 |
MA0150.1 | 0.34802 |
MA0151.1 | 0 |
MA0152.1 | 0.480711 |
MA0153.1 | 0.969315 |
MA0154.1 | 0.488402 |
MA0155.1 | 0.0402662 |
MA0156.1 | 0.288314 |
MA0157.1 | 0.652111 |
MA0158.1 | 0 |
MA0159.1 | 0.212043 |
MA0160.1 | 0.453945 |
MA0161.1 | 0 |
MA0162.1 | 0.14518 |
MA0163.1 | 0.00648562 |
MA0164.1 | 0.583138 |
MA0080.2 | 0.268439 |
MA0018.2 | 0.556211 |
MA0099.2 | 0.481058 |
MA0079.2 | 0.0127399 |
MA0102.2 | 1.41188 |
MA0258.1 | 2.29832 |
MA0259.1 | 1.82941 |
MA0442.1 | 0 |
ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data
(#promoters = Number of promoters in this coexpression cluster that have ChIP signal of the TF)
TF | #promoters | Enrichment | p-value | q-value |
---|---|---|---|---|
ESR1#2099 | 5 | 17.0936684978636 | 4.08817970262758e-06 | 0.000129895162751056 |
Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data
This analysis result is provided for C0 - C305 clusters.